Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ada Donà"'
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer
Autor:
Marilena Lanzino, Diego Sisci, Rosalinda Bruno, Michele Pellegrino, Federica Sotgia, Cinzia Giordano, Marco Fiorillo, Ida Perrotta, Elena Claire Ricci, Pietro Rizza, Catia Morelli, Alessandra Nigro, Daniela Bonofiglio, Michael P. Lisanti, Ada Donà
Publikováno v:
Cancers; Volume 11; Issue 12; Pages: 1858
Cancers
Cancers
Background: Resistance to endocrine treatments is a major clinical challenge in the management of estrogen receptor positive breast cancers. Although multiple mechanisms leading to endocrine resistance have been proposed, the poor outcome of this sub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5118da2b65ed1787b8274ff3176430c9
Autor:
Erika Cione, De Amicis F, Ada Donà, S. Aquila, Vincenza D, Diego Sisci, Carmela Guido, M. L. Panno, Marta Santoro
Publikováno v:
Oncology Reports. 35:568-576
Alterations in cellular metabolism are among the most consistent hallmarks of cancer. Herein, after a comprehensive metabolic phenotype characterization of MCF7 and ZR75 breast cancer cells, we investigated the activity of bergapten (Bg), a plant-der
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c5f9dba81fd09e63e79515061ac3184
https://doi.org/10.3892/or.2015.4327
https://doi.org/10.3892/or.2015.4327
Autor:
Francesca Giordano, Pietro Rizza, Diego Sisci, Daniela Bonofiglio, Carmela Guido, Michele Pellegrino, Maria Luisa Panno, Ada Donà, Francesca De Amicis, Marta Santoro, Sebastiano Andò, Ida Perrotta, Donatella Tramontano, Saveria Aquila
Publikováno v:
Oncotarget
// Francesca De Amicis 1, 2 , Carmela Guido 1, 2 , Marta Santoro 1 , Francesca Giordano 2 , Ada Dona 1, 2 , Pietro Rizza 2 , Michele Pellegrino 2 , Ida Perrotta 3 , Daniela Bonofiglio 1, 2 , Diego Sisci 1, 2 , Maria Luisa Panno 2 , Donatella Tramonta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7646e52f801912ee97b171c923bf4d44
http://hdl.handle.net/11588/785222
http://hdl.handle.net/11588/785222
Autor:
Paola Tucci, Sebastiano Andò, Saveria Aquila, Diego Sisci, Ivan Casaburi, Adele Vivacqua, Catia Morelli, Pietro Rizza, Michele Pellegrino, Maria Grazia Cesario, Paola Avena, Marilena Lanzino, Ada Donà
Publikováno v:
Oncotarget
Although the protective role of androgen receptor (AR) in breast cancer (BC) is well established, the mechanisms involved remains largely unexplored. MicroRNAs play fundamental roles in many biological processes, including tumor cell development and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0985d2cdc9850bf9ff17e817e8214b69
https://pubmed.ncbi.nlm.nih.gov/26862856
https://pubmed.ncbi.nlm.nih.gov/26862856
Autor:
Jayeeta Ghose, Ada Dona, Mariam Murtadha, Emine Gulsen Gunes, Enrico Caserta, Ji Young Yoo, Luke Russell, Alena Cristina Jaime-Ramirez, Benjamin G. Barwick, Vikas A. Gupta, James F. Sanchez, Douglas W. Sborov, Steven T. Rosen, Amrita Krishnan, Lawrence H. Boise, Balveen Kaur, Craig C. Hofmeister, Flavia Pichiorri
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss , Pp 519-531 (2021)
Because most patients with multiple myeloma (MM) develop resistance to current regimens, novel approaches are needed. Genetically modified, replication-competent oncolytic viruses exhibit high tropism for tumor cells regardless of cancer stage and pr
Externí odkaz:
https://doaj.org/article/65d17a0839584df484a779e3dc1740bf